Petredis Investment Advisors LLC Sells 100 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Petredis Investment Advisors LLC reduced its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 11,594 shares of the medical equipment provider’s stock after selling 100 shares during the quarter. Petredis Investment Advisors LLC’s holdings in Intuitive Surgical were worth $6,052,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. Berbice Capital Management LLC bought a new stake in shares of Intuitive Surgical in the 4th quarter valued at $26,000. Godsey & Gibb Inc. raised its holdings in shares of Intuitive Surgical by 140.0% during the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 35 shares during the period. MidAtlantic Capital Management Inc. bought a new position in shares of Intuitive Surgical during the 3rd quarter worth about $33,000. Decker Retirement Planning Inc. acquired a new stake in shares of Intuitive Surgical in the 4th quarter valued at about $36,000. Finally, Capital Performance Advisors LLP bought a new stake in Intuitive Surgical in the 3rd quarter valued at about $38,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

ISRG has been the subject of a number of research reports. Morgan Stanley raised Intuitive Surgical from an “equal weight” rating to an “overweight” rating and raised their price objective for the company from $522.00 to $650.00 in a research note on Monday, December 2nd. Stifel Nicolaus lifted their price target on shares of Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research report on Thursday, December 5th. Robert W. Baird upped their price objective on shares of Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a report on Thursday, October 17th. JPMorgan Chase & Co. lifted their price objective on shares of Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a report on Friday. Finally, Truist Financial upped their target price on shares of Intuitive Surgical from $640.00 to $666.00 and gave the stock a “buy” rating in a report on Friday. One research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $583.83.

Insiders Place Their Bets

In other Intuitive Surgical news, CEO Gary S. Guthart sold 18,151 shares of the stock in a transaction that occurred on Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total value of $9,286,596.13. Following the sale, the chief executive officer now directly owns 24,219 shares in the company, valued at $12,391,166.97. This represents a 42.84 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Jamie Samath sold 270 shares of the firm’s stock in a transaction on Tuesday, December 10th. The shares were sold at an average price of $540.15, for a total transaction of $145,840.50. Following the completion of the transaction, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at approximately $4,730,093.55. The trade was a 2.99 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 42,475 shares of company stock worth $22,070,807 over the last 90 days. Corporate insiders own 0.90% of the company’s stock.

Intuitive Surgical Stock Down 4.0 %

NASDAQ ISRG opened at $584.05 on Friday. The firm’s 50-day simple moving average is $546.03 and its two-hundred day simple moving average is $503.38. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00. The company has a market cap of $208.03 billion, a PE ratio of 93.90, a price-to-earnings-growth ratio of 5.19 and a beta of 1.39.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.